2016Cochrane Database of Systematic ReviewsRequires access

N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure

Jacky T.P. Siu, Aaron M Tejani, Trina Nguyen, Ricky D. Turgeon

Open publisher page 2 citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of N‐acetylcysteine compared with placebo in people with non‐paracetamol‐related acute liver failure.

About this research paper

What this paper is about

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of N‐acetylcysteine compared with placebo in people with non‐paracetamol‐related acute liver failure.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the benefits and harms of N‐acetylcysteine compared with placebo in people with non‐paracetamol‐related acute liver failure.

Key concepts: Acetylcysteine, Acetaminophen, Liver failure, Medicine, Placebo, acetaminophen overdose, Intervention (counseling), Protocol (science)

Related papers

Back to paper searchBrowse research topicsOriginal source
N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure — Research Paper | ScholarLens